• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 DNA 折纸术构建 TRAIL 三聚体的纳米级结构以促进死亡受体聚集和癌细胞凋亡

Nanoscale Organization of TRAIL Trimers using DNA Origami to Promote Clustering of Death Receptor and Cancer Cell Apoptosis.

机构信息

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, 11 Beiyitiao, Zhongguancun, Beijing, 100190, China.

State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan, Hubei, 430062, China.

出版信息

Small. 2023 Jun;19(23):e2206160. doi: 10.1002/smll.202206160. Epub 2023 Mar 8.

DOI:10.1002/smll.202206160
PMID:36890776
Abstract

Through inducing death receptor (DR) clustering to activate downstream signaling, tumor necrosis factor related apoptosis inducing ligand (TRAIL) trimers trigger apoptosis of tumor cells. However, the poor agonistic activity of current TRAIL-based therapeutics limits their antitumor efficiency. The nanoscale spatial organization of TRAIL trimers at different interligand distances is still challenging, which is essential for the understanding of interaction pattern between TRAIL and DR. In this study, a flat rectangular DNA origami is employed as display scaffold, and an "engraving-printing" strategy is developed to rapidly decorate three TRAIL monomers onto its surface to form DNA-TRAIL3 trimer (DNA origami with surface decoration of three TRAIL monomers). With the spatial addressability of DNA origami, the interligand distances are precisely controlled from 15 to 60 nm. Through comparing the receptor affinity, agonistic activity and cytotoxicity of these DNA-TRAIL3 trimers, it is found that ≈40 nm is the critical interligand distance of DNA-TRAIL3 trimers to induce death receptor clustering and the resulting apoptosis.Finally, a hypothetical "active unit" model is proposed for the DR5 clustering induced by DNA-TRAIL3 trimers.

摘要

通过诱导死亡受体 (DR) 聚集来激活下游信号,肿瘤坏死因子相关凋亡诱导配体 (TRAIL) 三聚体引发肿瘤细胞凋亡。然而,目前基于 TRAIL 的治疗方法的激动活性差限制了它们的抗肿瘤效率。不同配体间距离的 TRAIL 三聚体的纳米级空间组织仍然具有挑战性,这对于理解 TRAIL 与 DR 之间的相互作用模式至关重要。在这项研究中,采用平面矩形 DNA 折纸作为展示支架,并开发了一种“雕刻印刷”策略,将三个 TRAIL 单体快速装饰到其表面上,以形成 DNA-TRAIL3 三聚体(表面装饰有三个 TRAIL 单体的 DNA 折纸)。通过 DNA 折纸的空间可寻址性,可以精确控制配体间距离从 15 到 60nm。通过比较这些 DNA-TRAIL3 三聚体的受体亲和力、激动活性和细胞毒性,发现 ≈40nm 是 DNA-TRAIL3 三聚体诱导死亡受体聚集和导致凋亡的关键配体间距离。最后,提出了一个假设的“活性单位”模型,用于 DNA-TRAIL3 三聚体诱导的 DR5 聚集。

相似文献

1
Nanoscale Organization of TRAIL Trimers using DNA Origami to Promote Clustering of Death Receptor and Cancer Cell Apoptosis.使用 DNA 折纸术构建 TRAIL 三聚体的纳米级结构以促进死亡受体聚集和癌细胞凋亡
Small. 2023 Jun;19(23):e2206160. doi: 10.1002/smll.202206160. Epub 2023 Mar 8.
2
Clustering of Death Receptor for Apoptosis Using Nanoscale Patterns of Peptides.利用肽的纳米级图案对凋亡死亡受体进行聚类。
ACS Nano. 2021 Jun 22;15(6):9614-9626. doi: 10.1021/acsnano.0c10104. Epub 2021 May 21.
3
Death receptor 5 is activated by fucosylation in colon cancer cells.结肠癌细胞中岩藻糖基化激活死亡受体 5。
FEBS J. 2019 Feb;286(3):555-571. doi: 10.1111/febs.14742. Epub 2019 Jan 14.
4
Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.基于细胞死亡可视化和 TRAIL 死亡配体-受体相互作用预测体内促凋亡抗癌治疗反应。
Cancer Biol Ther. 2011 Aug 15;12(4):335-48. doi: 10.4161/cbt.12.4.17174.
5
Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors.六价 TRAIL 融合蛋白 Eftozanermin Alfa 通过最优聚集凋亡诱导型 TRAIL 受体诱导实体瘤中的靶抗肿瘤活性。
Cancer Res. 2021 Jun 15;81(12):3402-3414. doi: 10.1158/0008-5472.CAN-20-2178. Epub 2021 Mar 9.
6
DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.DR4特异性TRAIL变体在胰腺癌中比野生型TRAIL更有效。
Cancer Biol Ther. 2014;15(12):1658-66. doi: 10.4161/15384047.2014.972183.
7
Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.增强抗肿瘤细胞因子TRAIL对DR5受体选择性的突变增加其对肿瘤细胞的细胞毒性。
Biochemistry (Mosc). 2015 Aug;80(8):1080-91. doi: 10.1134/S0006297915080143.
8
Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.Importin β1 蛋白介导的死亡受体 5(DR5)核定位限制了 DR5/肿瘤坏死因子(TNF)相关凋亡诱导配体(TRAIL)诱导的人肿瘤细胞死亡。
J Biol Chem. 2011 Dec 16;286(50):43383-93. doi: 10.1074/jbc.M111.309377. Epub 2011 Oct 21.
9
A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer.一种新型 TRAIL 突变体-TRAIL-Mu3 通过增加 DR5 的亲和力和表达增强了胰腺癌的抗肿瘤作用。
Cancer Chemother Pharmacol. 2018 Nov;82(5):829-838. doi: 10.1007/s00280-018-3658-9. Epub 2018 Aug 24.
10
Functional roles of tumor necrosis factor-related apoptosis-inducing ligand-DR5 interaction in B16F10 cells by activating the nuclear factor-κB pathway to induce metastatic potential.肿瘤坏死因子相关凋亡诱导配体-DR5 相互作用通过激活核因子-κB 通路诱导 B16F10 细胞的转移潜能的功能作用。
Cancer Sci. 2013 May;104(5):558-62. doi: 10.1111/cas.12112. Epub 2013 Feb 28.

引用本文的文献

1
Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors.利用DNA纳米结构介导的死亡受体超聚集诱导癌细胞杀伤
Nano Lett. 2025 Apr 16;25(15):6310-6317. doi: 10.1021/acs.nanolett.5c01122. Epub 2025 Apr 8.
2
Cargo quantification of functionalized DNA origami for therapeutic application.用于治疗应用的功能化DNA折纸的货物定量
bioRxiv. 2024 Aug 27:2024.08.27.609963. doi: 10.1101/2024.08.27.609963.
3
DNA-modulated dimerization and oligomerization of cell membrane receptors.DNA 调控的细胞膜受体二聚化和寡聚化。
Chem Commun (Camb). 2024 Sep 16;60(75):10265-10279. doi: 10.1039/d4cc03077j.
4
A DNA robotic switch with regulated autonomous display of cytotoxic ligand nanopatterns.一种具有细胞毒性配体纳米图案调控自主展示功能的DNA机器人开关。
Nat Nanotechnol. 2024 Sep;19(9):1366-1374. doi: 10.1038/s41565-024-01676-4. Epub 2024 Jul 1.
5
Cell death shapes cancer immunity: spotlighting PANoptosis.细胞死亡塑造癌症免疫:聚焦 PANoptosis。
J Exp Clin Cancer Res. 2024 Jun 15;43(1):168. doi: 10.1186/s13046-024-03089-6.
6
Advanced applications of DNA nanostructures dominated by DNA origami in antitumor drug delivery.以DNA折纸术为主导的DNA纳米结构在抗肿瘤药物递送中的高级应用。
Front Mol Biosci. 2023 Aug 7;10:1239952. doi: 10.3389/fmolb.2023.1239952. eCollection 2023.
7
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.癌症中靶向p53信号通路:分子机制与临床研究
MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun.